The flu epidemic continues to go down. The positivity rate and other benchmarks for the week ending on Jan. 24 have dropped ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

New research finds vaccination decisions aren't primarily driven by weighing facts, but by what researchers call "gist"—the ...

Flu levels are rising once again across the United States, with emergency department visits increasing among children over 5, ...

U.S. flu cases are surging partially because of a new strain named "subclade K," that is not well covered by this year’s flu vaccine. Doctors still recommend getting the flu vaccine as it can reduce ...

Despite Sanofi CEO Paul Hudson’s confidence in vaccines, the French pharma has cut at least one mRNA flu shot program.

By Hugo Francisco de Souza Inside the rigorous, step-by-step process the CDC uses to create pandemic-ready flu vaccine ...

All viral activity benchmarks have gone down, except for a slight increase in the death rate. Here's what to know about the ...

Sanofi halts plan mRNA seasonal flu vaccine, stopping phase 1 trial but continues work on mRNA pandemic flu vaccine with promising data.

A multicomponent behavioral nudge intervention for clinicians and patients increased influenza vaccination rates among patients aged 50 years and older.